Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T19:41:39.188Z.
Calculation as of: 2026-10-06T19:41:39.188Z.
Quote observation: 2026-10-06T19:40:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
Market Cap
$131.16M
EV/Assets Ratio
0.67x
TTM Avg
0.54x
3Y Avg
0.61x
5Y Avg
0.90x
Market Cap
$135.97M
EV/Assets Ratio
0.23x
TTM Avg
0.43x
3Y Avg
0.43x
5Y Avg
0.43x
Market Cap
$131.57M
EV/Assets Ratio
0.95x
TTM Avg
1.66x
3Y Avg
1.85x
5Y Avg
2.17x
Market Cap
$136.58M
EV/Assets Ratio
0.25x
TTM Avg
0.41x
3Y Avg
0.41x
5Y Avg
0.50x
Market Cap
$138.03M
EV/Assets Ratio
4.76x
TTM Avg
7.19x
3Y Avg
5.37x
5Y Avg
4.39x
Market Cap
$139.08M
EV/Assets Ratio
1.51x
TTM Avg
1.48x
3Y Avg
2.84x
5Y Avg
2.84x
Market Cap
$127.51M
EV/Assets Ratio
2.99x
TTM Avg
6.41x
3Y Avg
6.40x
5Y Avg
17.01x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $133.18M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $131.55M | 1.88x | 2.43x | 3.96x | 3.52x |
| Health Catalyst, Inc. (HCAT)vs › | $131.16M | 0.67x | 0.54x | 0.61x | 0.90x |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.97M | 0.23x | 0.43x | 0.43x | 0.43x |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.57M | 0.95x | 1.66x | 1.85x | 2.17x |
| Organigram Global Inc. (OGI)vs › | $136.58M | 0.25x | 0.41x | 0.41x | 0.50x |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.03M | 4.76x | 7.19x | 5.37x | 4.39x |
| Alpha Cognition Inc (ACOG)vs › | $139.08M | 1.51x | 1.48x | 2.84x | 2.84x |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.51M | 2.99x | 6.41x | 6.40x | 17.01x |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.44M | 2.30x | 2.06x | 1.18x | 1.10x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
